These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25061755)
1. Screening for intellectual disability using high-resolution CMA technology in a retrospective cohort from Central Brazil. Pereira RR; Pinto IP; Minasi LB; de Melo AV; da Cruz e Cunha DM; Cruz AS; Ribeiro CL; da Silva CC; de Melo e Silva D; da Cruz AD PLoS One; 2014; 9(7):e103117. PubMed ID: 25061755 [TBL] [Abstract][Full Text] [Related]
2. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features. Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909 [TBL] [Abstract][Full Text] [Related]
4. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD. Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898 [TBL] [Abstract][Full Text] [Related]
5. Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability. Lee JS; Hwang H; Kim SY; Kim KJ; Choi JS; Woo MJ; Choi YM; Jun JK; Lim BC; Chae JH Ann Lab Med; 2018 Sep; 38(5):473-480. PubMed ID: 29797819 [TBL] [Abstract][Full Text] [Related]
6. Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India. Sharma P; Gupta N; Chowdhury MR; Sapra S; Ghosh M; Gulati S; Kabra M Gene; 2016 Sep; 590(1):109-19. PubMed ID: 27291820 [TBL] [Abstract][Full Text] [Related]
7. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil. Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800 [TBL] [Abstract][Full Text] [Related]
8. Application of chromosome microarray analysis in patients with unexplained developmental delay/intellectual disability in South China. Wang R; Lei T; Fu F; Li R; Jing X; Yang X; Liu J; Li D; Liao C Pediatr Neonatol; 2019 Feb; 60(1):35-42. PubMed ID: 29631977 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability. Borlot F; Regan BM; Bassett AS; Stavropoulos DJ; Andrade DM JAMA Neurol; 2017 Nov; 74(11):1301-1311. PubMed ID: 28846756 [TBL] [Abstract][Full Text] [Related]
10. [The diagnostic value of chromosome microarray analysis technique in the genetic causes of children with intellectual disability or global developmental delay]. Wu HR; Li L; Ma YN; Liu CL; Pei P; Zheng XF; Wang ST; Xiao Y; Bu DF; Xu YF; Pan H; Qi Y Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(3):224-228. PubMed ID: 33455150 [No Abstract] [Full Text] [Related]
11. [Value of copy number variation analysis and chromosomal karyotyping for the diagnosis of children with intellectual disability/developmental delay]. Lin M; Xue H; Wang Y; Huang H; Fu M; Guo N; Xu L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Mar; 38(3):228-231. PubMed ID: 33751530 [TBL] [Abstract][Full Text] [Related]
12. Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability. Li Y; Anderson LA; Ginns EI; Devlin JJ Mol Diagn Ther; 2018 Feb; 22(1):129-138. PubMed ID: 29209992 [TBL] [Abstract][Full Text] [Related]
13. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders. Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670 [TBL] [Abstract][Full Text] [Related]
14. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder. Shin S; Yu N; Choi JR; Jeong S; Lee KA Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil. Leite AJDC; Pinto IP; Leijsten N; Ruiterkamp-Versteeg M; Pfundt R; de Leeuw N; da Cruz AD; Minasi LB PLoS One; 2022; 17(4):e0266493. PubMed ID: 35390071 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability. Kim HJ; Park CI; Lim JW; Lee GM; Cho E; Kim HJ Yonsei Med J; 2018 May; 59(3):431-437. PubMed ID: 29611406 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic yield of the chromosomal microarray analysis in turkish patients with unexplained development delay/ıntellectual disability(ID), autism spectrum disorders and/or multiple congenital anomalies and new clinical findings. Akkus N; Cubuk PO Mol Biol Rep; 2024 Apr; 51(1):577. PubMed ID: 38664339 [TBL] [Abstract][Full Text] [Related]
18. Array-CGH increased the diagnostic rate of developmental delay or intellectual disability in Taiwan. Lee CL; Lee CH; Chuang CK; Chiu HC; Chen YJ; Chou CL; Wu PS; Chen CP; Lin HY; Lin SP Pediatr Neonatol; 2019 Aug; 60(4):453-460. PubMed ID: 30581099 [TBL] [Abstract][Full Text] [Related]
19. Low-pass whole genome sequencing as a cost-effective alternative to chromosomal microarray analysis for low- and middle-income countries. Mazzonetto PC; Villela D; Krepischi ACV; Pierry PM; Bonaldi A; Almeida LGD; Paula MG; Bürger MC; de Oliveira AG; Fonseca GGG; Giugliani R; Riegel-Giugliani M; Bertola D; Yamamoto GL; Passos-Bueno MR; Campos GDS; Machado ACD; Mazzeu JF; Perrone E; Zechi-Ceide RM; Kokitsu-Nakata NM; Vieira TP; Steiner CE; Gil-da-Silva-Lopes VL; Vieira DKR; Boy R; de Pina-Neto JM; Scapulatempo-Neto C; Milanezi F; Rosenberg C Am J Med Genet A; 2024 Nov; 194(11):e63802. PubMed ID: 38924610 [TBL] [Abstract][Full Text] [Related]
20. The clinical benefit of array-based comparative genomic hybridization for detection of copy number variants in Czech children with intellectual disability and developmental delay. Wayhelova M; Smetana J; Vallova V; Hladilkova E; Filkova H; Hanakova M; Vilemova M; Nikolova P; Gromesova B; Gaillyova R; Kuglik P BMC Med Genomics; 2019 Jul; 12(1):111. PubMed ID: 31337399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]